AI assistant
Sending…
Rua Bioscience Limited — Share Issue/Capital Change 2025
Sep 12, 2025
66262_rns_2025-09-12_97d5bcec-0862-492b-a419-bfbd6cd72f81.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Capital Change Notice
==> picture [78 x 33] intentionally omitted <==
| Section 1: Issuer information | |
|---|---|
| Name of issuer | Rua Bioscience Limited |
| NZX ticker code | RUA |
| Class of financial product | Ordinary shares |
| ISIN (If unknown, check on NZX website) | NZRUAE0004S1 |
| Currency | NZ$ |
| Section 2: Capital change details | |
| Number issued/acquired/redeemed | 1,333,333 ordinary shares |
| Nominal value (if any) | N/A |
| Issue/acquisition/redemption price per security | $0.03 |
| Nature of the payment (for example, cash or other consideration) |
Cash |
| Amount paid up (if not in full) | Paid in full |
| Percentage of total class of Financial Products issued/acquired/redeemed/ (calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence)1 |
Rua currently has 239,114,678 ordinary shares on issue and 5,591,201 warrants on issue. This issue of ordinary shares represents 0.54% of the total ordinary shares plus warrants on issue (being the percentage should all warrants vest and be exercised). |
| For an issue of Convertible Financial Products or Options, the principal terms of Conversion (for example the Conversion price and Conversion date and the ranking of the Financial Product in relation to other Classes of Financial Product) or the Option (for example, the exercise price and exercise date) |
N/A |
| Reason for issue/acquisition/redemption and specific authority for issue/acquisition/redemption/ (the reason for change must be identified here) |
Placement of new ordinary shares to fund short-term working capital requirements and authorised by a Board resolution on 9th September 2025. |
| Total number of Financial Products of the Class after the issue/acquisition/redemption/Conversion (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue/acquisition/redemption. |
Total ordinary shares on issue: 240,448,011 ordinary shares Total warrants on issue: 5,591,201 warrants |
| In the case of an acquisition of shares, whether those shares are to be held as treasury stock |
N/A |
1 The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.
| Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue, acquisition, or redemption is made |
Board resolution and Listing Rule 4.5.1 |
|---|---|
| Terms or details of the issue, acquisition, or redemption (for example: restrictions, escrow arrangements) |
Issue of ordinary shares which rank equally with all other fully paid ordinary shares |
| Date of issue/acquisition/redemption | 11/9/2025 |
| Section 3: Authority for this announcement and contact person | |
| Name of person authorised to make this announcement | Paul Naske |
| Contact person for this announcement | Paul Naske |
| Contact phone number | 021 445 154 |
| Contact email address | [email protected] |
| Date of release through MAP | 12/09/2025 |
More from Rua Bioscience Limited
Director's Dealing
2026
May 22
Share Issue/Capital Change
2026
May 21
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 12
Interim / Quarterly Report
2026
Feb 26
Director's Dealing
2026
Jan 20
Major Shareholding Notification
2026
Jan 20
Director's Dealing
2026
Jan 19
Director's Dealing
2026
Jan 19
Major Shareholding Notification
2026
Jan 15